by John Conrad | Jun 27, 2024 | NewsBrief
Tempus AI, Inc. (NASDAQ: TEM) has achieved a significant milestone in the field of artificial intelligence and precision medicine. The company recently announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its innovative...
